Topic Review
Breast Cancer with Brain Metastasis
Breast cancer is the most frequently diagnosed malignancy worldwide and the leading cause of cancer-related death among women. Brain metastases are a primary contributor to mortality, as they often go undetected until late stages due to their dormant nature. Moreover, the clinical management of brain metastases is complicated by the relevant issue of blood-brain barrier penetration.
  • 245
  • 31 May 2023
Topic Review
Magnetic Resonance Imaging Approach in Renal Tumors
Ultrasound and computed tomography (CT) have been the mainstay of renal mass screening and diagnosis but advances in magnetic resonance (MR) technology have made this the optimal choice when diagnosing and staging renal tumors. 
  • 277
  • 31 May 2023
Topic Review
Belantamab Mafodotin
Belantamab Mafodotin, a first-in-class anti-B cell maturation antigen (BCMA) antibody–drug conjugate, demonstrated good efficacy and safety profile in triple-refractory patients in the phase 2 DREAMM-2 trial, and it was approved for the treatment of MM triple-exposed patients with >4 prior lines of therapy. 
  • 445
  • 31 May 2023
Topic Review
Focused Ultrasound-Mediated Blood–Brain Barrier Opening for Neurological Disorders
Several therapeutic agents for neurological disorders are usually not delivered to the brain owing to the presence of the blood–brain barrier (BBB), a special structure present in the central nervous system (CNS). Focused ultrasound (FUS) combined with microbubbles can reversibly and temporarily open the BBB, enabling the application of various therapeutic agents in patients with neurological disorders. 
  • 360
  • 31 May 2023
Topic Review
Possible Mechanisms of Atrial Fibrillation in Athletes
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, and it is an enormous burden worldwide because of its high morbidity, disability and mortality. It is generally acknowledged that physical activity (PA) is strongly associated with a significant reduction in the risk of cardiovascular (CV) disease and all-cause mortality. Moreover, it has been observed that moderate and regular physical activity has the potential to reduce the risk of AF, in addition to improving overall well-being.
  • 265
  • 31 May 2023
Topic Review
Voltage-Gated Sodium Channel in Neurodegenerative Diseases
The pore-forming subunits (α subunits) of voltage-gated sodium channels (VGSC) are encoded in humans by a family of nine highly conserved genes. Among them, SCN1A, SCN2A, SCN3A, and SCN8A are primarily expressed in the central nervous system. The encoded proteins Nav1.1, Nav1.2, Nav1.3, and Nav1.6, respectively, are important players in the initiation and propagation of action potentials and in turn of the neural network activity. In the context of neurological diseases, mutations in the genes encoding Nav1.1, 1.2, 1.3 and 1.6 are responsible for many forms of genetic epilepsy and for Nav1.1 also of hemiplegic migraine. Conversely, VGSCs seem to have a modulatory role in the most common neurodegenerative diseases such as Alzheimer’s, where SCN8A expression has been shown to be negatively correlated with disease severity.
  • 428
  • 30 May 2023
Topic Review
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers
Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures. These nanocarriers may enhance the solubility and permeability of drugs, increase their bioavailability, and extend the residence time in the body, combining low toxicity with a targeted delivery. Nanostructured lipid carriers are the second generation of lipid nanoparticles differing from solid lipid nanoparticles in their composition matrix. The use of a liquid lipid together with a solid lipid in nanostructured lipid carrier allows it to load a higher amount of drug, enhance drug release properties, and increase its stability. Therefore, a direct comparison between solid lipid nanoparticles and nanostructured lipid carriers is needed. 
  • 655
  • 30 May 2023
Topic Review
Plant Toxic Proteins
Plants evolve to synthesize various natural metabolites to protect themselves against threats, such as insects, predators, microorganisms, and environmental conditions (such as temperature, pH, humidity, salt, and drought). Plant-derived toxic proteins are often secondary metabolites generated by plants. These proteins, including ribosome-inactivating proteins, lectins, protease inhibitors, α-amylase inhibitors, canatoxin-like proteins and ureases, arcelins, antimicrobial peptides, and pore-forming toxins, are found in different plant parts, such as the roots, tubers, stems, fruits, buds, and foliage.
  • 329
  • 30 May 2023
Topic Review
Gender-Specific Pharmacokinetics and Pharmacodynamics
Women and men respond differently to treatments; this mainly depends on physiological, anatomical, and hormonal characteristics. The existence of the differences in therapeutic agent pharmacokinetics and pharmacodynamics influences the response to treatments.
  • 428
  • 30 May 2023
Topic Review
Epithelial–Mesenchymal Transition in Salivary Adenoid Cystic Carcinoma
Salivary adenoid cystic carcinoma (SACC) is considered the second most frequent malignant salivary gland neoplasm and exhibits a controversial and poorly understood biological behavior, characterized by slow and indolent growth. SACC typically arises from the submandibular gland and minor salivary glands, while its occurrence in the parotid gland is relatively rare. SACC has an incidence rate of approximately 4.5 cases per million individuals and constitutes 10% of all salivary gland tumors (SGTs). This type of cancer exhibits three distinct histological growth patterns, namely cribriform, tubular, and solid patterns. Among these patterns, the solid pattern represents the most aggressive form of SACC with an increased risk of metastasis, resulting in shorter disease-specific survival.
  • 245
  • 30 May 2023
  • Page
  • of
  • 1352
Video Production Service